Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of Autologous CD4^LVFOXP3 in Participants With Immune Dysregulation Polyendocrinopathy Enteropathy X-linked (IPEX) Syndrome

NCT05241444 is registered in ClinicalTrials.gov with Bacchetta, Rosa, MD as lead sponsor.

NCT NCT05241444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05241444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of Autologous CD4^LVFOXP3 in Participants With Immune Dysregulation Polyendocrinopathy Enteropathy X-linked (IPEX) Syndrome
Lead sponsor
Bacchetta, Rosa, MD
Phase
Phase 1
Overall status
Recruiting
Start date
March 22, 2022
Completion date
February 28, 2037
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ipex